BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8312949)

  • 1. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
    Zambelli S; Zanin A; Gaglio A; Zai G; Bosco E; Andrion A; Magnani C
    Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
    Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
    Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
    Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
    Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
    Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
    Cohen MB; Waldman FM; Carroll PR; Kerschmann R; Chew K; Mayall BH
    Hum Pathol; 1993 Jul; 24(7):772-8. PubMed ID: 8100555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
    Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
    Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
    Goyal S; Singh UR; Sharma S; Kaur N
    Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNOR/P53 expression compared with different grades in bladder carcinoma.
    Karakök M; Aydin A; Bakir K; Uçak R; Korkmaz C
    Int Urol Nephrol; 2001; 33(2):353-5. PubMed ID: 12092655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
    Zoeller J; Flentje M; Sinn P; Born IA
    Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
    Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
    Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
    Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
    Micron; 2007; 38(6):674-9. PubMed ID: 17011198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma.
    Pich A; Valente G; Azzoni L; Stramignoni A; Margaria E; Tasso M
    Pathol Res Pract; 1991 May; 187(4):482-6. PubMed ID: 1715079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nucleolar organizer region in bladder cancer. Relationship with histologic grade, stage, and prognosis].
    Rivera P; Roa I
    Actas Urol Esp; 1994 Mar; 18(3):204-6. PubMed ID: 8036947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
    Mourad WA; Sneige N; Katz RL; Ordóñez NG
    Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.